USEP Performance — Innovator U.S. Equity Ultra Buffer ETF - September
Data updated: 2026-09-28
USEP returned +6.09% year to date and +11.25% over one year to Jul 2026. Annualised returns are +11.77% over 3 years and +8.16% over 5 years. The fund beat its Trading - Leveraged category average: $100 invested three years ago grew to $140, against $136 for the category, and to $111 over one year, against $105. Volatility over the past three years was 6.57% a year. In the 12 months to Jul 2026 the fund took in a net $1.1M, and assets reached $148.07M.
USEP Growth of $100
What $100 invested in Innovator U.S. Equity Ultra Buffer ETF - September grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | USEP | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $111 | $105 |
| 3 years (Aug 2023 – Jul 2026) | $140 | $136 |
| 5 years (Aug 2021 – Jul 2026) | $148 | $130 |
| Since data start (Feb 2020 – Jul 2026) | $164 | $143 |
USEP Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.09% |
| 1 year | +11.25% |
| 3 years (annualised) | +11.77% |
| 5 years (annualised) | +8.16% |
USEP Annual Returns
Calendar-year total returns of Innovator U.S. Equity Ultra Buffer ETF - September, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.09% |
| 2025 | +11.55% |
| 2024 | +12.44% |
| 2023 | +19.05% |
| 2022 | −8.19% |
| 2021 | +5.85% |
| 2020 (Feb–Dec) | +6.65% |
USEP Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.7% | 0.0% | −2.2% | +4.8% | +1.7% | +0.4% | +0.8% | — | — | — | — | — |
| 2025 | +1.5% | −0.5% | −3.4% | −0.2% | +3.9% | +3.3% | +1.8% | +1.5% | +1.7% | +0.8% | +0.3% | +0.5% |
| 2024 | +1.1% | +2.5% | +1.4% | −1.1% | +2.6% | +1.0% | +0.6% | +0.7% | +1.4% | −0.4% | +2.7% | −0.7% |
| 2023 | +3.6% | −1.5% | +2.3% | +1.4% | +0.4% | +4.7% | +1.9% | +0.7% | −2.8% | −1.2% | +5.4% | +2.9% |
| 2022 | −1.5% | −1.2% | +1.4% | −4.1% | −0.1% | −1.9% | +0.5% | −0.5% | −4.9% | +4.0% | +2.9% | −2.6% |
| 2021 | −0.7% | +0.8% | +1.8% | +0.9% | +0.4% | +0.4% | +0.3% | +0.1% | −1.8% | +2.6% | −0.6% | +1.5% |
| 2020 | — | −2.5% | −5.5% | +5.4% | +2.3% | +0.5% | +2.4% | +1.1% | −1.1% | −0.6% | +3.9% | +1.0% |
USEP Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.57%
- 3-year Sharpe ratio: 1.11 (vs 4.5% risk-free rate)
- Best month: +5.41% (Nov 2023)
- Worst month: −3.41% (Mar 2025)
USEP Fund Flows
Monthly money in and out of Innovator U.S. Equity Ultra Buffer ETF - September, from SEC Form N-PORT.
- 12-month net flow: $1.1M
- 12-month gross sales (incl. reinvestments): $229.5M
- Sales ÷ redemptions: 1.00×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $5.2M | −$5.2M |
| Jun 2026 | $0 | $3.1M | −$3.1M |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $4.0M | −$4.0M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $981K | $64.2M | −$63.2M |
| Jan 2026 | $0 | $9.9M | −$9.9M |
| Dec 2025 | $0 | $6.9M | −$6.9M |
| Nov 2025 | $1.9M | $1.9M | $0 |
| Oct 2025 | $0 | $1.9M | −$1.9M |
| Sep 2025 | $98.8M | $0 | $98.8M |
| Aug 2025 | $127.7M | $131.3M | −$3.6M |
USEP Assets Under Management
Net assets of Innovator U.S. Equity Ultra Buffer ETF - September by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $148.07M |
| 2026-04-30 | $152.01M |
| 2026-01-31 | $215.84M |
| 2025-10-31 | $228.97M |
| 2025-07-31 | $129.34M |
| 2025-04-30 | $130.32M |
| 2025-01-31 | $178.79M |
| 2024-10-31 | $161.56M |
| 2024-07-31 | $56.96M |
| 2024-04-30 | $60.29M |
| 2024-01-31 | $89.50M |
| 2023-10-31 | $88.11M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.